MedTrace Logo

ZOE Health Study: The Intermittent Fasting Study

NCT05558423 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 150000

Last updated 2022-11-30

No results posted yet for this study

Summary

The timing of food intake (chrononutrition) is emerging as a key regulator of circadian rhythm in metabolic organs. A wealth of research has been conducted on intermittent fasting, and time restricted eating (TRE) specifically, investigating the temporal patterns of diet (eating window, time of eating, time of largest energy intake) and their impact on disease risk, with overall beneficial impact on health. Studies have been conducted in a parallel or single arm design, while cross-over and the efficacy of TRE in ameliorating appetite and symptom burden within an individual remains unclear.

Conditions

  • Intermittent Fasting
  • Time Restricted Feeding

Interventions

BEHAVIORAL

Time Restricted Eating

Participants are asked to follow a Time Restricted Eating regimen with eating window of ≤10 hours.

Sponsors & Collaborators

Principal Investigators

  • Tim Spector, Pr · Zoe Ltd, King's College London

Study Design

Allocation
NA
Purpose
BASIC_SCIENCE
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-10-24
Primary Completion
2023-10-24
Completion
2023-10-24

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05558423 on ClinicalTrials.gov